The toolkit has been developed in conjunction with the RSPCA and includes a welfare workflow, quick download guides and welfare case forms. It can be downloaded here .
Merry Smith, a BEVA council member who led the project on behalf of BEVA, said: "Welfare assessments can sometimes be intimidating and it’s natural to feel vulnerable, particularly when circumstances are difficult. Our new Welfare Case Toolkit gives you access to the information and resources, even when you are on the road, to support you in dealing with a welfare case."
The interactive Welfare Workflow provides a step-by-step guide to what happens when a vet is called upon to provide an opinion on the health and welfare of the animals involved. It has been produced in a mobile-friendly format or can be printed out and kept in the car. Supporting the Workflow is a series of quick downloads, covering all aspects of the process:
Approach to the welfare case
Letter of instruction
Section 18 of the Animal Welfare Act (2006) certificate
Witness details sheet
Witness statement form
RSPCA vet exam form
Guidance notes on how to complete a vet exam welfare case form
Caroline Allen, Chief Veterinary Officer at the RSPCA said: "Vets are absolutely critical to the work of the RSPCA and while we know many vets get a lot of satisfaction from this work saving animals from cruelty and suffering, we know that this work can sometimes be daunting and the law confusing. We are delighted to have worked with BEVA on providing this guidance and hope it is the first step in us providing more support to vets doing this vital work- we literally couldn't do it without you"
The Welfare Case Toolkit is available free to BEVA members https://www.beva.org.uk/Resources-For-Vets-Practices/Clinical-Practice-Guidance/Welfare-guidance/Welfare-toolkit
The webinar, which is presented by equine internal medicine specialist David Rendle from Rainbow Equine Hospital, challenges some of the current perceptions of worm control in horses and explains why veterinary surgeons need to engage more with horse owners on the topic to ensure a sustainable approach to parasite control.
Supported by Virbac, maker of Equimax and Eraquell horse wormers, the webinar is free to BEVA members at http://www.ebeva.org/webinar74.
Representatives from all sectors of the veterinary profession are encouraged to apply for the role, which is to represent veterinary surgeons in those regions to BVA Council and help shape the association's strategy and policy development.
Candidates are required to be based in the region they represent and to have time available to commit to gathering members’ views on key policy areas, representing those views at three meetings per year in London, and one elsewhere in the UK (attached to BVA Members’ Day). They will also need to meet members at local events where possible, and promote the good name and values of BVA. All of this work is supported by BVA headquarters.
The term of the BVA regional representative role is for three years. It suits motivated individuals who are interested in current issues affecting the profession. BVA pays your expenses and you’ll get free BVA membership for the duration of your term.
Daniella Dos Santos, President of the British Veterinary Association (pictured right), said: "BVA Council plays a key role in helping us to achieve our mission as the leading body representing, supporting and championing the whole UK veterinary profession. Our regional representatives are integral to that mission and to the activities of Council - contributing to effective horizon scanning on matters of veterinary policy and providing an informed steer to BVA’s Policy Committee.
"With an increasingly complex veterinary landscape, and wide range of issues and potential outcomes for animal health and welfare and the veterinary profession it’s essential that members have the best person to represent them at the highest level within BVA."
Emma Callaghan, BVA Scottish Branch regional representative and 2019 Bleby Cup winner, added: "I am currently in the middle of my first term on BVA Council and I would encourage anyone who is considering taking part to put themselves forward for election. This is a fantastic chance to represent the views of your region and to help BVA members to get their voices heard. I’m really enjoying my time as a regional representative - it’s been such a wonderful opportunity to meet a range of people from across the profession and to develop new skills outside my day-to-day role."
BVA members who are interested in becoming a representative for their area can apply before 9am on 16 December 2019 when nominations close. For more information or to submit your application, visit www.bva.co.uk/council/
Kriptazen is supplied with a twist-adjustable and weight-graduated dosing pump which means farmers can administer a precise dose up to 60kg without having to calculate it in ml’s first. Virbac says this will help to reduce the risk of incorrect dosing and toxicity issues.
Virbac’s Technical Product Manager Rosie Naylor said: "We are delighted to bring Kriptazen to the market. The trusted active halofuginone, along with the innovative weight graduated dosing pump, provides practices with added peace of mind when it comes to treatment."
For more information, contact your Virbac Territory Manager.
At his first Disciplinary Committee hearing in January 2018, the Committee directed that Dr Gerhard Schulze Allen’s name be removed from the Register after finding him guilty of serious professional misconduct in respect of four charges against him. These related to an incident of petty theft in California in the United States, and his subsequent dishonesty in not disclosing this to the College.
Following the Disciplinary Committee hearing, Dr Schulze Allen submitted an appeal to the Privy Council. In July 2019, the Privy Council partially upheld his appeal, determining that the RCVS had not proven beyond all reasonable doubt that Dr Schulze Allen’s infraction for petty theft was a conviction under Californian law and therefore Dr Schulze Allen had not made false representations to the College when he said he did not have any criminal convictions or a criminal record.
However, the Privy Council partially upheld the College’s charge that Dr Schulze Allen was dishonest and made false representations when he had, in a written application for restoration to the Register, represented that he did not have any adverse findings and that he should have declared his infraction for petty theft. The Privy Council also set aside the Disciplinary Committee’s original sanction and remitted the task of sanction back to the Disciplinary Committee.
As a result of the Privy Council’s decision, the Disciplinary Committee held a further hearing in relation to Dr Schulze Allen to decide the sanction in relation to the upheld charge against him.
The Committee noted that the aggravating factors were the fact that Dr Schulze Allen was dishonest to his regulator and in making a false declaration, demonstrated a wilful disregard for the regulatory role of the RCVS. In mitigation the Committee considered that there was no harm to animals, that it was a single and isolated incident in an otherwise unblemished career, and that he had accepted his wrongdoing, albeit at a late stage, and was developing some insight.
The Committee considered whether a reprimand or warning would be the most appropriate sanction but determined that this would not reflect the seriousness of the dishonesty in this case, nor maintain public confidence in the profession or uphold proper professional standards of conduct and behaviour.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee concluded that the appropriate and proportionate sanction is suspension from the Register for a period of three months. A period of three months reflects the seriousness of the charge. Such a sanction sends a clear message to Dr Schulze Allen, the profession and the public that behaving dishonestly towards the regulator is a serious matter. The Committee considered that removal from the Register would be disproportionate given that this is a single incident and Dr Schulze Allen now accepts his wrongdoing."
The Scottish Fold is bred for a cartilage abnormality which gives them their distinctive folded ears.
However, that same cartilage abnormality affects their joints, meaning that they go on to develop painful arthritis, even from a young age.
The charities say the impact of using this breed in a Hollywood film cannot be overstated and is likely to significantly increase their popularity with potential cat owners.
Nathalie Dowgray, Head of ISFM, said: “International Cat Care (iCatCare) and its veterinary division, the International Society of Feline Medicine (ISFM), believe that it is simply unethical to continue to breed cats with a genetic mutation that is known to cause significant painful disease – the rationale for breeding these cats was purely for traits considered attractive to humans, as some people believe the folded ears look appealing.
"This is an unnatural appearance for a cat, and the underlying genetic defect has far-reaching and severe consequences for the health of the cat.
"Health should always be more important than looks.”
The trailer for the film also shows a cat travelling in a backpack and subjected to rough handling, including being picked up by the scruff and thrown from a building.
ISFM says that although these scenes have been created using digital animation, the organisations share concerns that suggesting these interactions with cats are acceptable or entertaining may have a negative impact on the welfare of cats.
Sarah Ellis, Head of Cat Mental Wellbeing and Behaviour at International Cat Care, said: “Scruffing a cat is an unacceptable form of restraint that can cause a cat considerable discomfort, fear and even pain, as the weight of its body is completely unsupported, and the cat cannot escape the pressure from its skin being grasped.
"Backpacks are not a cat friendly way to transport a cat; they can leave a cat cramped, without enough ventilation, struggling to control body temperature, and uncomfortable due to the unpredictable movement from being worn on a person’s back.
"Backpacks are simply not cat friendly - they do not respect the cat as a species and run the risk of psychological and physical suffering to the cat.”
The organisations have contacted Universal Pictures, asking them to adopt Cat Friendly Principles in future, and not to promote cat breeds with extreme features in future.
I invited Marc Abraham to come and answer some of the concerns raised on VetSurgeon about the ITV Pets Undercover programme.
His PR agency has instead pointed me in the direction of a response he has posted on his own website this morning. Click the link below.
http://www.marcthevet.com/response-to-%e2%80%98pets-undercover%e2%80%99/
In the survey of 354 owners, 65% thought their cats get on well with each other. However, 60% reported signs of disharmony, including: chasing (65%), swiping paws (53%), hissing (48%), keeping a distance from one another (31%), fighting and acting aggressively (27%), staring (30%) and sitting in front of resources to block access (25%).
In addition, some of the cats were so stressed that they would often scratch furniture or household items (46%), hide from their housemates (26%), meow excessively (20%) or spray (17%).
Claire Russell, Feliway brand manager at Ceva Animal Health, said: "There is the common misconception that cats need other feline companions, however they are naturally solitary survivors who are more than happy in their own company. Simple environmental changes and using Feliway Friends can help restore harmony between household cats who are displaying signs of multi-cat tension."
Reference
A free copy of the compendium has been sent to every veterinary practice in the UK, and it is also available online at: www.noahcompendium.co.uk. A special edition of the book commissioned by AMTRA will also be available for its SQPs shortly.
NOAH chief executive Dawn Howard said: "The NOAH Compendium, in all its formats, remains a major part of NOAH’s efforts to ensure appropriate access and responsible use of medicines for all animals. We are pleased it is even more comprehensive this year, as we continue to expand its list of contributors.
"Every NOAH member, as well as the non-member participants in the NOAH Compendium, is a signatory to the NOAH Code of Practice on Promotion, which demonstrates their commitment to operate above and beyond any regulatory requirements."
She added: “As well as product datasheets, the Compendium includes another vital resource – the contact details for each participating company. Company veterinary and technical advisors have detailed knowledge about their company’s medicines. The NOAH Code includes the requirement for NCAH qualification for NOAH staff in technical dialogue with prescribers and users of animal medicines – meaning their advice can be regarded as a valuable and trusted resource. They are ready to talk to prescribers about the use of a medicine in a particular animal or in a particular situation, as well as to explain any queries about the data sheet."
Veterinary practices that have not yet received a copy, perhaps because they are new or have changed address in the past year should contact NOAH (noah@noah.co.uk).
Extra copies are also available to order, for £47.50. Special prices are also available for bulk orders.
The CPD-qualifying webinar is being given by Professor Saul Faust, Professor of Paediatric Immunology & Infectious Diseases at the University of Southampton, and Ian Wright MRCVS, a veterinary parasitologist, Head of ESCCAP UK & Ireland and one of the owners of The Mount Veterinary Practice in Lancashire.
The webinar will reveal the real threat of this disease and its impact on sufferers, and give an insight to the challenges of diagnosing the condition.
Register for the webinar here: https://cloud.mc.zoetis.com/beneath-the-fur-webinar
Currently Principal of the Royal Veterinary College, University of London, and previously Dean of the University of Glasgow’s School Of Veterinary Medicine, Stuart has been a member of RCVS Council since 2005, and served as RCVS President in 2014-15.
As chair of the Education Policy and Specialisation Committee in 2011, Stuart oversaw the College’s review of veterinary specialisation, which also led to the new Advanced Practitioner status.
He has also been a driving force behind the joint RCVS and BVA Vet Futures project since its inception in 2015.
As Chair of the RCVS Governance Panel, he recently saw through reform of the College’s governance arrangements to improve the efficiency and accountability of its decision-making processes.
Stuart has also chaired the RCVS Science Advisory Panel.
He continues to chair the College’s Mind Matters Initiative, which aims to improve the mental health and wellbeing of all those in the veterinary team.
A particularly notable achievement during his Presidential year was to allow UK veterinary surgeons to use the courtesy title ‘Doctor’ if they so wished.
Lizzie Lockett, RCVS Chief Executive said: "We have been incredibly fortunate to have someone of Stuart’s calibre, character and international renown on our Council for so many years. His contributions and commitment to the RCVS, as well as to the wider veterinary professions, are as significant as they are often understated.
"On behalf of RCVS Council and all the staff, I should like to say how delighted we are that he has been honoured in this way. Such recognition is very much deserved and we send him our warmest congratulations."
During the webinar, which took place earlier this month, senior officers and staff from the College explained the new guidance, what it will mean for the profession, and answered questions submitted by delegates.
The webinar was chaired by RCVS President Dr Melissa Donald MRCVS with a panel comprising Standards Committee Chair Linda Belton MRCVS, RCVS Registrar Eleanor Ferguson, and RCVS Head of Standards Gemma Kingswell.
The webinar included an overview of the main changes, the considerations to take into account when prescribing POM-Vs remotely, the circumstances under which POM-Vs cannot be prescribed remotely, the prescription of antibiotics, antifungals, antiparasitics and antivirals, and how the guidance will be enforced.
Eleanor Ferguson, RCVS Registrar, said: “We have also now published a range of practice-based scenarios to help explain how the new guidance should be followed in various circumstances, and in relation to different species.
"These scenarios cover a variety of different situations, including how the guidance applies to two or more practices with mutual clients, consultancy services and the prescription of long-term controlled drugs.”
A second webinar will be held on Monday 17th July, with priority for those who wanted to attend the June webinar but were not able to do because it was over-subscribed.
www.rcvs.org.uk/undercare
The Ear Protector sits on the back of the head and hooks onto face mask strings, pulling them backwards and away from the ears, thereby relieving pressure and stopping chafing.
The product was designed by AMufacture's Chief Operating Officer, William Howden, a former Olympic sailor who competed in the 2008 Summer Olympics in Beijing. He said: "Early in the pandemic, it became apparent to us that there was a serious need to address an unresolved problem with face masks – people were really beginning to suffer and were getting distracted from their work."
The Ear Protector is sterilisable in a dishwasher. It is also recyclable when it reaches the end of its life.
The Ear Protectors cost fifty pence each, for orders of two hundred. Contact the company direct for lower volume pricing.
For more information, visit: http://www.theearprotector.com
Lots of April Fool's Day gags involving animals this year...
watch?v=1kC0OI9MYZc
The Sun reported that Sir Richard Branson's health club chain, Virgin Active, is launching a new gym for dogs only, to combat the pet obesity epidemic. Alton Towers supposedly launched a new rollercoaster ride for dogs only. Meanwhile, Pasante, a condom manufacturer, launched the 'condog', though this seems to be a variation on an idea that has been around for a while now.
My favourites, though, were two April fools unrelated to animals. The first was from Cadbury's, made more believable by the fact that it was planted in the Southampton Echo. The second was the announcement by BMW that Dr. Noit All, the company's Head of Innovation, had developed a fuel-saving system called Magnetic Tow Technology (MTT). Readers were invited to keep abreast with future developments from BMW by emailing Dr. Noit All's colleague at uve.vollenvorit@bmw.co.uk.
The Best UK Vets Awards are given to the practices that accumulate the largest number of positive reviews from clients on vethelpdirect.com and any-uk-vet.co.uk over the course of the year.
Penmellyn Vets achieved 839 positive ratings; 200 more than their nearest rivals, reflecting the tremendous level of engagement they have with their clients, something which also shone through in the sentiments expressed in their client reviews.
Penmellyn Vets is an independent practice owned by six veterinary surgeons, who are all based in Cornwall. They have been providing veterinary care to the pets and horses of Cornwall for over 130 years. They still cover their own out of hours’ care and their services include preventative healthcare packages for their cat and dog-owning clients, ‘LifeCare’ and ‘LifeCare+’. The latter grants clients access to unlimited vet and nurse consultations 6 days a week – something that is currently only offered by Penmellyn Vets in Cornwall.
Philip Harris, one of the partners at Penmellyn Vets said: "We are absolutely delighted to have won this award and want to say thank you to each and every one of our clients who took the time to leave a review. And my thanks to the Penmellyn staff for their hard work and commitment to providing the outstanding customer service that has been recognised by this award. I couldn’t be more proud of them. We’re an independent practice and very traditional in many ways, so I think as we’ve grown as a group, with a goal of excellence always in patient care, our values have kept us grounded and very client-centric. We look forward to celebrating the award with our team at the awards ceremony in the coming weeks."
Blacks Vets in Dudley were awarded the Silver award after receiving a very commendable 620 qualifying client reviews.
Tracey Jewkes, Managing Director, said: "We are delighted to have been awarded Silver in the Best UK Vet 2017 Award and would like to take this opportunity to send a heartfelt thank you to our wonderful clients for voting for us again this year. Our consistency at the top of this award for the past 3 years is a reflection of both the calibre and heart Team Blacks give to pets, clients and each other year after year. We could not be more proud of each and every team member here, nor could we feel more privileged to take great care of so many much loved pets in our local community."
Inglis Veterinary Hospital in Dunfermline, Scotland received 358 qualifying reviews and received the Bronze award. They also went on to win the Best Scottish Vet Award 2017.
The full list of winners is:
This year’s winners of the small category awards are:
Ian graduated from the University of Liverpool and gained his PhD from the University of Glasgow. He gained both the UK and European Diplomas in Small Animal Medicine at the University of Cambridge and is a Royal College of Veterinary Surgeons and European Recognised Specialist in Small Animal Medicine. He returned to Glasgow University in 1998 and has been the Professor of Small Animal Medicine since 2009.
Ian has published in the fields of infectious diseases, endocrinology and neurology but is interested in all aspects of small animal medicine. In 2015 he was awarded the BSAVA Woodrow Award for his contribution to small animal medicine. In 2016 he became of Fellow of the RCVS, thereby becoming a jolly good fellow Fellow of the RCVS, or JGFFRCVS for short.
Professor Ramsey has served BSAVA as a regional secretary, member of several committees and chair of Petsavers and Scientific. He is probably best known as the editor of four editions of the BSAVA Small Animal Formulary.
The Presidential handover usually takes place at BSAVA Congress but was delayed this year given the cancellation of the April event due to coronavirus.
Ian says that during his Presidency, he intends to promote and enhance the digital offering of the Association to BSAVA members coping with the pandemic. He will also oversee changes to BSAVA congress with a more interactive approach to training; shortened, more focussed lectures and greater integration between the exhibition, the scientific content, and the social events.
Ian said: “At this time of great uncertainty in the profession, my focus will be on providing BSAVA members with the scientific information and clinical training that they need, in a suitable form. Clinical skills and science lie at the heart of being a good vet and BSAVA members get access to a huge range of cheap or free resources in these areas to help them in their careers. Congress 2021 will be evolving as a vital part of this effort and I am looking forward to welcoming everyone to Manchester during the last week of March 2021."
The study was part of a research project called VetCompass, through which the RVC, in collaboration with Vets Now, collects anonymised clinical information on over 6 million companion animals under veterinary care in the UK.
The study investigated bitches presented with difficulty giving birth (dystocia) from among almost 20,000 bitches attending 50 Vets Now surgeries. Researchers found that out of 20,000 bitches receiving emergency veterinary care, 3.7 per cent of these were treated because of difficulties encountered giving birth.
The most commonly affected breeds were the French Bulldog (15.9 times more likely), Boston Terrier (12.9 times more likely), Chihuahua (10.4 times more likely) and Pug (11.3 times more likely).
Dr Dan O’Neill, a companion animal epidemiologist within the VetCompass Programme, said: "Giving birth in dogs is not always a benign process and our research shows this risk is especially exacerbated in some common brachycephalic and toy breeds. Prospective owners should bear these welfare costs for high risk breeds in mind when choosing their new puppy."
Caroline Kisko, Kennel Club Secretary, said: 'VetCompass' research will not only enable dog breeders to make responsible breeding choices to improve the health of these dogs, it will help to highlight what puppy buyers need to be looking out for if they are intent on owning one of these breeds. If people are choosing a breed simply for its looks and are not going to a reputable breeder, they are likely to face high vet costs and a lifetime of heartache."
This study builds on previous 'purchasing' research by the RVC which found that appearance is the number one reason why owners purchase flat-faced breeds, even though their large, round, wide-set eyes, and flat rounded faces are linked with a variety of inherited diseases.
Dr Rowena Packer, lead author of the study and Research Fellow at RVC, said: "Potential puppy buyers attracted to the appearance of these breeds should seriously consider whether they are emotionally and financially prepared to take on a breed with high risks of health complications, and consider whether alternative, lower-risk breeds would better fit their lifestyle."
Ceva says this is the first time it has advertised Feliway Friends - designed to help cats live together in harmony - on television. It will be rotating the Feliway advert with one explaining the benefits of the Adaptil Calm On-the-Go Collar.
Both advertisements are 30 seconds long and the campaign runs until the end of June. It will target 24.5 million pet owners and will air on all Channel 4 and Channel 4 partner channels, including Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home.
Abigail King, product manager for Feliway and Adaptil at Ceva, said: "Our summer TV advertising campaign will raise awareness of how Feliway Friends and Adaptil Calm On-the-Go Collar can help pets with behavioural issues and drive customers to veterinary practices for further information and to purchase product."
For further information, visit www.feliway.com or www.adaptil.com.
The survey found that 51% of cat and dog owners didn't research their pets breed before buying. Of the 22% who then regretted their decision, 31% said it was because they didn’t have enough time to look after the animal, 18% because they turned out to be allergic to the animal, and 16% because they didn’t like their pet’s personality.
Apparently dog owners were more likely to regret their new pet (26%) than cat owners (16%).
Sainsbury’s has therefore launched the Pawfect Match tool, designed to help future pet owners to make informed decisions when choosing the most suitable breed for them. The pet picker asks you a number of questions about your circumstances and makes a number of suggestions based on how you answer.
Sainsbury's campaign is being fronted by Scott Miller MRCVS, who said: "I am saddened to hear that so many pet owners are regretting the animals they have chosen as companions. Dogs and cats come in all shapes and sizes, and have different temperaments. Looking after a pet is a huge commitment so it is important that people undertake adequate research before buying a pet to ensure it is a happy experience."
COMMENT
I tried Sainsbury's pet picker and it recommended a Basset Hound as the first choice. Fair enough. I always think they look like the living embodiment of the word 'hangdog', which is not really my cup of tea. Luckily, the tool makes more than one suggestion. One of the criteria I'd specified was 'quiet and calm', so the second recommendation, a whippet, was fine. But the third caught my eye. A Border Collie. What? Whaaaaaat? Quiet and calm? A Border Collie. Are you having a laugh? I thought Border Collies usually need to be sent to some sort of asylum.
Still, if Sainsbury's tool encourages more people to think harder about their choice, that's no bad thing. But they might like to rethink the Border Collie recommendation.
Boehringer Ingelheim Vetmedica has launched Prascend, the first licensed product for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses, commonly known as Equine Cushing's Disease.
Prascend contains pergolide mesylate, and is supplied in 60 and 160 tablet packs of 1mg tablets.
Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "Many horses and ponies with Cushing's Disease benefit from treatment with pergolide, however, with less than 200 people still being treated with pergolide in the UK, many vets and horse owners have expressed concern that they will not be able access treatment in the future.
"We have invested in dedicated veterinary manufacturing of this product, and can assure our customers that the future supply of Prascend is guaranteed irrespective of any changes of in the human generic market."
For further information, visit www.prascend.co.uk or call 01344 746959
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a Schedule Two Controlled Drug, without having to complete the online training programme which was has been mandatory since the launch of the product in April 2013.
The company says that training is still highly recommended for every veterinary professional that handles Recuvyra due to its new delivery system. This can be via the short online training course available at www.recuvyratraining.eu or by reading the training leaflet provided with every vial of Recuvyra. The training leaflet includes information on instructions for use, correct administration of the product and special precautions. In addition, client leaflets and other support materials will continue to be available to vets via the website.
Alice Laurens, Recuvyra product manager at Elanco Companion Animal Health, said: "Veterinary practices will still need to follow their wholesalers' procedures for ordering Schedule Two Controlled Drugs when purchasing Recuvyra, however any vet from the practice can now order and sign for delivery of the product making it easier to purchase."
For further information about Recuvyra or Elanco's surgery and pain management range, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
Clive Elwood, Ian Battersby, Laurent Garosi, Nat Whitley and David Gould have all become Fellows for Meritorious Contributions to Clinical Practice. Meanwhile, Jerry Davies, founder of Davies Veterinary Specialists, has become a Fellow for Meritorious Contributions to the Profession.
The consultation, which was held by the College early in 2017, asked for the views of veterinary surgeons and nurses, animal owners, and stakeholders on the use of telemedicine in veterinary clinical practice.
The consultation was designed to help identify potential risks associated with telemedicine, identify areas where it may help address the needs of both clinicians and the public, and support the potential development of new professional standards and guidance.
The online survey of veterinary professionals received 1,230 responses, while the public consultation received 229 responses and the survey of organisations/stakeholders received eight responses.
The headline question asked of veterinary professionals was whether RCVS 'supporting guidance to the Code of Professional Conduct' should be amended to allow remote examination to take the place of physical examination in certain circumstances. 41% said 'Yes', 40% said 'No' and 18% were unsure.
Veterinary professionals and organisations were then asked a series of questions in order to establish how they rated the risk associated with telemedicine according to activity type, practice type, clinical sign or syndrome, mode of technology, and familiarity with client, animal or environment.
Unsurprisingly perhaps, the majority felt that providing just general advice presented a low risk. At the other end of the scale, most felt that the use of telemedicine to diagnose disease or injury would be either 'high risk', or 'not appropriate at all'.
Likewise, the majority said the risks would be low or medium where the client and environment were known and the animal seen before, for the same problem. By contrast, the majority said telemedicine would be either 'high risk' or 'not appropriate at all' when the client, animal and environment were all unknown.
When asked whether the current definition of 'under care' should be extended to allow veterinary surgeons to prescribe veterinary medicines where there has been no physical examination of the animal, 69% said 'No', 16% said 'Yes' and 15% were unsure.
However, when asked whether certain types of veterinary medicines should be able to be prescribed without a physical examination of the animal, the majority of respondents to the professional survey (52%) were in favour.
The results of the consultation were first considered at a special meeting of the Standards Committee in August 2017, where it was noted how the consultation had revealed significant confusion around current supporting guidance to the RCVS Code of Professional Conduct and that, at a minimum, clarification as to what was currently permissible was needed.
The Committee determined a key issue going forward was whether to change the Supporting Guidance to the RCVS Code of Professional Conduct regarding 'under care' to allow veterinary surgeons to prescribe POM-V medicines based on telemedicine alone.
Given the complex nature of the issues and the wide-ranging implications, the Standards Committee presented a range of options for amending RCVS Guidance to RCVS Council at its meeting in November 2017. After discussion, Council asked the Standards Committee to continue their review and to present more detailed proposals to Council regarding the future of telemedicine in clinical veterinary practice.
Anthony Roberts, RCVS Director of Leadership and Innovation, said: "We would like to thank all those who took the time to respond to the consultation – although Council has not yet made any firm decisions, we felt it would be useful to share our research so far.
"The use of telemedicine is growing rapidly in human healthcare and it is only right the RCVS assesses the opportunities it could bring to improve access to veterinary services. It is critical, however, that we understand the issues it presents 'at the coal face' and consider all the available evidence before making any changes to our Guidance. The RCVS should ensure its regulatory framework fosters innovation and maximises the opportunities to improve the quality, efficacy and accessibility of veterinary services, whilst at the same time protecting animal health and welfare."
The Standards Committee will meet again in April 2018 to take further evidence and develop proposals to take the issue forward.
Meanwhile, the full summary is available on the College’s website: www.rcvs.org.uk/telemeds-summary/.
James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."
Bimeda says the benefits of Tetroxy Vet include:
Tetroxy Vet is available in a 100ml pack size.
In one case, Tigga, a 17-year-old cat with an itchy and destructive tumour on her nose, was in complete remission within 44 days. In another case, a tumour vanished in a dog where the aim of the treatment was only to shrink the mass before an operation to remove it.
NDSR, which is based in Bletchingley, is the only referral centre in the UK and one of very few in the world offering electrochemotherapy in pets.
Electrochemotherapy is given in two stages.
First, the patient is given a mild dose of intravenous chemotherapy in the normal way and then, using a probe, a precise electrical charge is given to the area on or around the tumour.
This temporarily opens up tiny holes in the cells, big enough to allow the drug to enter, which then close again in microseconds. This means the drug will only attack cancerous cells, unlike normal chemotherapy, which also kills healthy cells.
Gerry Polton, clinical director of oncology at NDSR, said: "Normal chemotherapy works on the principle of being more damaging to cancer than non-cancerous tissue. Some cancers are more resilient, so there are differences in how they respond to treatment, and this can cause more harm to the patient.
"Electrochemotherapy involves clever anatomical targeting of a specific site and is an effective way of protecting healthy cells.
"The results we are seeing in cases like Tigga’s are unprecedented and we are learning about the procedure all the time. We are always looking for better ways of treating cancer without the effect of harming the patient indiscriminately and this has proved to be a very effective way of doing this."
According to NDSR, the results could help inform the development of the targeted treatment in humans, where electrochemotherapy is used in a small number of cases in the NHS.
At present, many clinical trials are carried out on laboratory animals which are bred with no immune system – but dogs have similarities in genetics to humans and have working immune systems, meaning they can provide a more accurate parallel for how the treatment may work in people.
Gerry said: "A pet dog would be a good model for human cancer studies. It's a mammal with a heartbeat, blood supply and working immune system.
"Progress with electrochemotherapy in animals is being made in parallel with progress in electrochemotherapy in the human field, and what we are learning may even inform what is happening in people.
"Electrochemotherapy is a form of treatment which Cancer Research UK describe as 'fairly new' on its website, with limited information about its effectiveness. So maybe something would be gained from learning together."